Tygh Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tygh Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,785	Closed	-$456K	–	100
2016 Q1	$456K	Sell	2,785 -2,953	-51%	-$599K	0.13%	90
2015 Q4	$1.88M	Buy	5,738 +3,011	+110%	+$980K	0.53%	73
2015 Q3	$879K	Sell	2,727 -1,020	-27%	-$448K	0.21%	85
2015 Q2	$1.49M	Buy	3,747 +1,923	+105%	+$817K	0.27%	94
2015 Q1	$898K	Sell	1,824 -2,717	-60%	-$1.05M	0.17%	101
2014 Q4	$1.63M	Buy	+4,541	New	+$1.35M	0.31%	90

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Tygh Capital Management's LUMO Position: Q2 2016 in Review

Tygh Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 2,785 shares — an estimated $456K sold.

Tygh Capital Management first reported a position in LUMO in Q4 2014 and held it in 6 quarters. The position peaked at $1.88M in Q4 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

Tygh Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Tygh Capital Management sold 2,785 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $456K.
Tygh Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 6 quarters.
Tygh Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $1.88M in Q4 2015.
112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Tygh Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.